COMMUNIQUÉS West-GlobeNewswire

CLS Holdings USA Announces Closing of Oversubscribed C$13.0 Million Private Placement
25/06/2018
TORONTO and LAS VEGAS, June 25, 2018 (GLOBE NEWSWIRE) -- CLS Holdings USA, Inc. (OTCQB:CLSH) “CLS,” a development stage diversified cannabis company operating as Cannabis Life Sciences, is pleased to announce the [...]
PDC Hosts 8th Annual Brady Walk for Community to Raise Funds for Local Charities in Southern California
25/06/2018
Proceeds will be Donated to Michael Hoefflin Foundation and Speak Out Against Bullying VALENCIA, Calif., June 25, 2018 (GLOBE NEWSWIRE) -- PDC , a global leader of innovative identification solutions, will host the 8 th [...]
PositiveID Subsidiary Chief Science Officer Joins Cambridge Healthtech Institute’s 26th Biodetection Technologies: Biothreat and Pathogen Detection
25/06/2018
PositiveID ExcitePCR subsidiary develops FireflyDX products for rapid, portable biothreat detection, a key to containment DELRAY BEACH, Fla., June 25, 2018 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “ [...]
Tyme Technologies, Inc. Set to Join Russell 3000® Index
25/06/2018
NEW YORK, June 25, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ:TYME), a clinical-stage oncology company developing metabolically-based cancer therapeutics, today announced it is set to join the Russell 3000 [...]
Vital Therapies Joins the Russell 3000 Index®
25/06/2018
SAN DIEGO, June 25, 2018 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD ® , a cell-based therapy targeting the treatment of acute forms of liver failure, announced it [...]
Evelo Biosciences Added To Russell 3000®, 2000® and Microcap® Indexes
25/06/2018
CAMBRIDGE, Mass., June 25, 2018 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company pioneering monoclonal microbials designed to act on the gut-body network for the [...]
Novelion Therapeutics Announces Presentation of Positive Metreleptin Data at American Diabetes Association Scientific Sessions
25/06/2018
Data Show Leptin Replacement Therapy Sustainably Decreased Weight Over Time in Patients with Low Baseline Leptin Levels Company plans to initiate Phase 2 proof of concept study in hypoleptinemic metabolic disorder (HMD [...]
Immune Design Presents Data on the Mechanism of Action of G100 via TLR4 Expressed in B Cell Malignancies at the Inaugural AACR International Meeting Advances in Malignant Lymphoma
25/06/2018
- G100 directly targets and modifies TLR4 expressing malignant B cells making them more visible to the anti-tumor immune response- SEATTLE and SOUTH SAN FRANCISCO, Calif., June 25, 2018 (GLOBE NEWSWIRE) -- Immune Design [...]
Celsion Corporation to Join Russell Microcap® Index
25/06/2018
LAWRENCEVILLE, N.J., June 25, 2018 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced that it will be added to the Russell Microcap® Index as part of the [...]
Cannabis Leaf (PCFP) Completes Merger with Apotheca Biosciences – Company’s R & D Focuses on Opioid Crisis, a National Public Health Emergency
25/06/2018
Saint Petersburg, FL, June 25, 2018 (GLOBE NEWSWIRE) -- Cannabis Leaf (OTC PINK: PCFP), a developer of cutting-edge medical products, nutraceuticals, formulation and cannabis delivery technologies for the healthcare and [...]
Mustang Bio Added to Russell 2000®, 3000® and Microcap® Indexes
25/06/2018
NEW YORK, June 25, 2018 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ:MBIO), a Fortress Biotech (NASDAQ:FBIO) Company focused on the development of novel immunotherapies based on proprietary chimeric antigen [...]
Caelum Biosciences Announces Complete Cardiac Data Analysis from Phase 1b Trial of CAEL-101 in AL Amyloidosis
25/06/2018
Nine of 10 cardiac patients on CAEL-101 showed improvement in global longitudinal strain CAEL-101 led to sustained decrease in NT-proBNP levels Data presented at American Society of Echocardiography 29th Annual [...]
PolarityTE Added to Russell 3000® and Russell 2000® Indexes
25/06/2018
SALT LAKE CITY, June 25, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (COOL), a commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of patients by discovering, designing [...]
ADMA Biologics Added to the Russell 3000 and Russell 2000 Indexes
25/06/2018
RAMSEY, N.J. and BOCA RATON, Fla., June 25, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ:ADMA), a vertically integrated commercial biopharmaceutical company that manufactures, markets and develops specialty [...]
Zafgen Set to Join Russell 3000® Index
25/06/2018
BOSTON, June 25, 2018 (GLOBE NEWSWIRE) -- Zafgen, Inc., (Nasdaq:ZFGN), a clinical-stage biopharmaceutical company leveraging its proprietary MetAP2 biology platform to develop novel therapies for patients affected by [...]
Novo Nordisk A/S - Share repurchase programme
25/06/2018
Bagsværd, Denmark, 25 June 2018 - On 4 May 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR [...]
Medtronic Receives CE Mark for MiniMed(TM) 670G Hybrid Closed Loop System
25/06/2018
DUBLIN - June 25, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received CE (Conformité Européenne) Mark for the MiniMed(TM) 670G hybrid closed loop system - the first [...]
Helius Medical Technologies, Inc. Joins Russell 3000® Index, Russell 2000® Index and Russell Microcap® Index
25/06/2018
NEWTOWN, Pa., June 25, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, announced today that the [...]
EyePoint Pharmaceuticals Announces Stockholder Approval of Second Tranche of Capital Financing
25/06/2018
Expected closing of $25.5 million in capital to be used to accelerate EyePoint’s transformation into a commercial-stage specialty biopharmaceutical company Financing supports two near-term product launches anticipated [...]

Pages